Who is sponsoring ELEVATE UC 52?

ELEVATE UC 52 is sponsored by Arena Pharmaceuticals.

What condition does ELEVATE UC 52 study?

ELEVATE UC 52 studies Ulcerative Colitis.

What drugs are being tested in ELEVATE UC 52?

Interventions: Etrasimod, Placebo.

What is the status of ELEVATE UC 52?

ELEVATE UC 52 is currently COMPLETED.

Last reviewed 2022-12-20 · How we verify

Etrasimod Versus Placebo for the Treatment of Moderately to Severely Active Ulcerative Colitis (ELEVATE UC 52)

NCT03945188 PHASE3 COMPLETED Results posted

The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for moderately to severely active ulcerative colitis.

Details

Lead sponsor	Arena Pharmaceuticals
Phase	PHASE3
Status	COMPLETED
Enrolment	433
Start date	Thu Jun 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Feb 16 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Ulcerative Colitis

Interventions

Etrasimod
Placebo

Countries

Italy, Taiwan, Poland, South Korea, Lebanon, Croatia, Denmark, Netherlands, Russia, Belgium, Estonia, Mexico, Lithuania, Bulgaria, Thailand, Czechia, Portugal, United States, Latvia, France, South Africa, Slovakia, Serbia, Austria, Chile, Israel, Hungary, Argentina, Canada, Romania